Last year, during the first wave, a global study titled “The emergence of Covid-19 associated Mucormycosis: Analysis of cases from 18 countries” was done on 80 patients, 42 of them were from India. One of the noted microbiologists, Arunaloke Chakarabatri, MD, Professor, Department of Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh was part of this study team. The study had established that 41 out of 42 patients from India had a fungal infection in the sinuses, nasal passage, oral cavity, and brain. Only one patient had it in the lungs. Such infections were not found so widely among patients in developed countries.